KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for NovoCure (NVCR) over the last 11 years, with Q3 2025 value amounting to 0.49.

  • NovoCure's Asset Utilization Ratio rose 379.63% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year increase of 379.63%. This contributed to the annual value of 0.51 for FY2024, which is 1637.87% up from last year.
  • Per NovoCure's latest filing, its Asset Utilization Ratio stood at 0.49 for Q3 2025, which was up 379.63% from 0.51 recorded in Q2 2025.
  • NovoCure's Asset Utilization Ratio's 5-year high stood at 0.51 during Q2 2025, with a 5-year trough of 0.44 in Q2 2023.
  • For the 5-year period, NovoCure's Asset Utilization Ratio averaged around 0.47, with its median value being 0.47 (2022).
  • As far as peak fluctuations go, NovoCure's Asset Utilization Ratio tumbled by 4745.41% in 2021, and later skyrocketed by 1060.87% in 2024.
  • Quarter analysis of 5 years shows NovoCure's Asset Utilization Ratio stood at 0.47 in 2021, then dropped by 3.98% to 0.45 in 2022, then dropped by 2.27% to 0.44 in 2023, then increased by 10.61% to 0.49 in 2024, then grew by 0.25% to 0.49 in 2025.
  • Its last three reported values are 0.49 in Q3 2025, 0.51 for Q2 2025, and 0.5 during Q1 2025.